ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

In Brief: AACR Voted On Naming Delegates To Congress, Not On Attending; ACCC Membership Over 300

February 17, 1978

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

In Brief: Breast Cancer Diet Study Problems Resolved, Funding Resumed For Nutrition Coordinator

April 19, 1985

In Brief: Winston Ho Heads Saint Joseph Bone Marrow Transplant Unit; Smoking Cost $452 Bil. A Year

March 16, 1990

Buenos Aires Academy Denies Argentina Prosecutes Scientist

July 28, 1978